long-term fertil leydig cell function patient germ cell cancer cisplatin vinblastin versu surveil fertil leydig cell function patient nonseminomat testicular cancer twenty-two patient metastat cancer cisplatin-bas chemotherapi median follow-up month rang month nine patient metastas orchiectomi follow-up group median month rang month none patient retroperiton lymph node dissect patient concentr spermatozoa volum testi patient chemotherapi patient orchiectomi signific differ group morpholog motil penetr spermatozoa subclin leydig cell dysfunct normal testosteron hormon LH patient orchiectomi patient chemotherapi LH cisplatin-bas chemotherapi persist impair fertil leydig cell function major patient testicular cancer 